PubMed Health⌕ Search

Biomedical subjects

M V de Albarenque

Publications and source records attributed to M V de Albarenque.

2 recordsLinked to original sources

A quantitative method for evaluating the effects of drugs on bone marrow cellularity using the same experimental animal. Quantification of the effects of a single dose of busulphan.

A method for quantifying the cellularity of rats bone marrow per unit of weight is described. Absolute numbers of each cell type per mg of bone marrow in the left and right femurs of the same experimental animal were determined at different times. In normal rats in which both femurs were studied simultaneously it was found that the absolute counts of each cell type per mg of bone marrow in the left and right femurs did not differ, nor were differences found in absolute numbers of marrow cells when the quantitative analyses from the left femurs were compared with those of the right femurs of the same animal, 10 and 20 days later. In order to test the validity of the present method for evaluating the effects of drugs on hematopoiesis, a single oral dose of busulphan (20 mg/kg), was administered to normal rats immediately after the marrow quantitative studies of the left femurs were performed. A marked and significant reduction in total nucleated cell was seen in marrows from the right femurs, 10 days later. Cellular effects were particularly pronounced on the myeloid line. Results presented here indicate that the quantitative study employed is a simple and useful method to evaluate the effects of drugs on hematopoiesis. The novelty of this method lies in: 1) its expression of cellularity on a per mg marrow basis, thereby avoiding possible misinterpretations of data which occur when results are expressed as percentages and 2) the analysis of contralateral femoral marrow specimens obtained from the same animal before and after drugs treatment. Therefore, each animal acts as its own control avoiding possible errors in the determination of drug-induced hematopoietic changes due to inter-animal variability.

Animals↗

Erythropoietic action of dexamethasone on the anemia associated with an experimental chronic renal failure.

Partially nephrectomized anemic uremic rats were injected with dexamethasone phosphate (10, 50 and 500 micrograms/kg/day), i.p., and erythropoietin (5 U/day), s.c., for 10 days. A marked and usually significant stimulatory effect on erythropoiesis was seen in all uremic animals treated. Administration of erythropoietin and dexamethasone produced a pronounced increment in hemoglobin, hematocrit and circulating reticulocytes. The increase in red blood cell production was also evident through the generally increased absolute numbers of nucleated erythroid cell precursors per milligram of bone marrow. The highest increases were seen in the erythropoietin treated uremic rats. A dose effect correlation was apparent in uremic rats receiving 3 different doses of dexamethasone. Dexamethasone may stimulate erythropoiesis in our anemic uremic rats through a previous augmentation of erythropoietin production in the residual renal mass. A synergistic permissive effect of dexamethasone increasing the sensitivity of the erythropoietin-responsive cells to erythropoietin in bone marrow is also quite possible.

Anemia↗